- Home
- CDTX vs WALD Comparison
CDTX vs WALD Comparison
Compare CDTX & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- WALD
- Stock Information
- Founded
- CDTX 2012
- WALD 1988
- Country
- CDTX United States
- WALD United States
- Employees
- CDTX N/A
- WALD N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- WALD Package Goods/Cosmetics
- Sector
- CDTX Health Care
- WALD Consumer Discretionary
- Exchange
- CDTX Nasdaq
- WALD Nasdaq
- Market Cap
- CDTX 333.3M
- WALD 291.5M
- IPO Year
- CDTX 2015
- WALD 2021
- Fundamental
- Price
- CDTX $21.02
- WALD $2.25
- Analyst Decision
- CDTX Strong Buy
- WALD Strong Buy
- Analyst Count
- CDTX 9
- WALD 5
- Target Price
- CDTX $41.29
- WALD $5.16
- AVG Volume (30 Days)
- CDTX 202.2K
- WALD 123.4K
- Earning Date
- CDTX 08-12-2025
- WALD 07-01-2025
- Dividend Yield
- CDTX N/A
- WALD N/A
- EPS Growth
- CDTX N/A
- WALD N/A
- EPS
- CDTX N/A
- WALD N/A
- Revenue
- CDTX $302,000.00
- WALD $273,868,000.00
- Revenue This Year
- CDTX N/A
- WALD $14.78
- Revenue Next Year
- CDTX N/A
- WALD $15.84
- P/E Ratio
- CDTX N/A
- WALD N/A
- Revenue Growth
- CDTX N/A
- WALD 25.55
- 52 Week Low
- CDTX $10.14
- WALD $1.98
- 52 Week High
- CDTX $28.42
- WALD $4.74
- Technical
- Relative Strength Index (RSI)
- CDTX 39.72
- WALD 42.65
- Support Level
- CDTX $21.14
- WALD $2.09
- Resistance Level
- CDTX $22.60
- WALD $2.50
- Average True Range (ATR)
- CDTX 1.54
- WALD 0.16
- MACD
- CDTX -0.51
- WALD -0.01
- Stochastic Oscillator
- CDTX 12.57
- WALD 25.58
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.